Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
Most Cited Paper
in Heart Failure Treatment and Management
18 Months Post-Publication
Class of 2026
“Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
GLP-1 receptor agonist · SGLT2 inhibitors · Combination therapy · type 2 diabetes · Major adverse cardiovascular events · serious renal events · Myocardial infarction · Stroke · Cardiovascular mortality · Heart failure · All-cause mortality · population based cohort study · prevalent new-user design · UK Clinical Practice Research Datalink · time conditional propensity score · Cox proportional hazards model
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-08-20. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459